IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 130 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,496,000 | +23.6% | 424,864 | +28.4% | 0.01% | +40.0% |
Q3 2016 | $5,254,000 | +31.4% | 330,843 | +8.2% | 0.01% | +25.0% |
Q2 2016 | $4,000,000 | +22.0% | 305,902 | +2.0% | 0.00% | +33.3% |
Q1 2016 | $3,280,000 | +124.4% | 299,831 | +137.7% | 0.00% | +50.0% |
Q4 2015 | $1,462,000 | -26.1% | 126,130 | -33.6% | 0.00% | 0.0% |
Q3 2015 | $1,978,000 | +5.3% | 189,826 | +21.9% | 0.00% | 0.0% |
Q2 2015 | $1,878,000 | +3.8% | 155,698 | +37.6% | 0.00% | 0.0% |
Q1 2015 | $1,810,000 | +20.3% | 113,131 | +15.2% | 0.00% | 0.0% |
Q4 2014 | $1,505,000 | +13.1% | 98,208 | -4.4% | 0.00% | +100.0% |
Q3 2014 | $1,331,000 | -22.3% | 102,755 | -8.1% | 0.00% | -50.0% |
Q2 2014 | $1,714,000 | +13.7% | 111,789 | -8.7% | 0.00% | +100.0% |
Q1 2014 | $1,508,000 | -53.5% | 122,425 | -56.2% | 0.00% | -66.7% |
Q4 2013 | $3,242,000 | -0.1% | 279,242 | +1.9% | 0.00% | 0.0% |
Q3 2013 | $3,245,000 | -28.0% | 274,111 | -39.6% | 0.00% | -40.0% |
Q2 2013 | $4,505,000 | – | 453,660 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |